Libra Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.20 M
- Company Age 17 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.40 M
- Revenue Growth 17.25%
- Profit Growth 47.57%
- Ebitda 45.37%
- Net Worth 55.63%
- Total Assets 75.46%
About Libra Biotech
Libra Biotech Private Limited (LBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 December 2007 and has a history of 17 years and one month. Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.20 M.
The company has closed loans amounting to ₹4.40 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajender Verma and Tajender Sharma serve as directors at the Company.
Company Details
-
Location
Ghaziabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999UP2007PTC034340
-
Company No.
034340
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Dec 2007
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Libra Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajender Verma
|
Director | 26-Dec-2007 | Current |
|
Tajender Sharma
|
Director | 26-Dec-2007 | Current |
Financial Performance of Libra Biotech.
Libra Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.25% increase. The company also saw a substantial improvement in profitability, with a 47.57% increase in profit. The company's net worth Soared by an impressive increase of 55.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Libra Biotech?
In 2022, Libra Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹4.40 M
Charges Breakdown by Lending Institutions
- Others : 0.22 Cr
- Bank Of Maharashtra : 0.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Dec 2019 | Others | ₹2.20 M | Satisfied |
| 11 Jun 2012 | Bank Of Maharashtra | ₹2.20 M | Satisfied |
How Many Employees Work at Libra Biotech?
Libra Biotech has a workforce of 58 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Libra Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Libra Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.